Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam J Adler

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Translational Research : the Journal of Laboratory and Clinical Medicine|November 21, 2017
Macrophage polarization and meta-inflammationChuan Li, Maria M Xu, Kepeng Wang, et al.
Parasites & Vectors|October 10, 2009
Blood feeding by the Rocky Mountain spotted fever vector, Dermacentor andersoni, induces interleukin-4 expression by cognate antigen responding CD4+ T cellsVenkata D Boppana, Saravanan Thangamani, Francisco J Alarcon-Chaidez, et al.
Immunotherapy|December 22, 2016
Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapyAdam J Adler, Payal Mittal, Joseph M Ryan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2021
Lymphocyte Activation Gene-3 Regulates Dendritic Cell Metabolic Programing and T Cell Priming FunctionDunia Garcia Cruz, Raghavendra R Giri, Daylin Gamiotea Turro, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2018
A novel biologic platform elicits profound T cell costimulatory activity and antitumor immunity in miceJoseph M Ryan, Payal Mittal, Antoine Menoret, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector functionAmy D H Doody, Joseph T Kovalchin, Marianne A Mihalyo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapyMarianne A Mihalyo, Amy D H Doody, Jeremy P McAleer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cellsAdam T Hagymasi, Aaron M Slaiby, Marianne A Mihalyo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 13, 2015
Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor TherapyPayal Mittal, Marie-Clare St Rose, Xi Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expressionMeixiao Long, Aaron M Slaiby, Adam T Hagymasi, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Translational Research : the Journal of Laboratory and Clinical Medicine|November 21, 2017
Macrophage polarization and meta-inflammationChuan Li, Maria M Xu, Kepeng Wang, et al.
Parasites & Vectors|October 10, 2009
Blood feeding by the Rocky Mountain spotted fever vector, Dermacentor andersoni, induces interleukin-4 expression by cognate antigen responding CD4+ T cellsVenkata D Boppana, Saravanan Thangamani, Francisco J Alarcon-Chaidez, et al.
Immunotherapy|December 22, 2016
Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapyAdam J Adler, Payal Mittal, Joseph M Ryan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2021
Lymphocyte Activation Gene-3 Regulates Dendritic Cell Metabolic Programing and T Cell Priming FunctionDunia Garcia Cruz, Raghavendra R Giri, Daylin Gamiotea Turro, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2018
A novel biologic platform elicits profound T cell costimulatory activity and antitumor immunity in miceJoseph M Ryan, Payal Mittal, Antoine Menoret, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Glycoprotein 96 can chaperone both MHC class I- and class II-restricted epitopes for in vivo presentation, but selectively primes CD8+ T cell effector functionAmy D H Doody, Joseph T Kovalchin, Marianne A Mihalyo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapyMarianne A Mihalyo, Amy D H Doody, Jeremy P McAleer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2007
Steady state dendritic cells present parenchymal self-antigen and contribute to, but are not essential for, tolerization of naive and Th1 effector CD4 cellsAdam T Hagymasi, Aaron M Slaiby, Marianne A Mihalyo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 13, 2015
Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor TherapyPayal Mittal, Marie-Clare St Rose, Xi Wang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 6, 2006
T-bet down-modulation in tolerized Th1 effector CD4 cells confers a TCR-distal signaling defect that selectively impairs IFN-gamma expressionMeixiao Long, Aaron M Slaiby, Adam T Hagymasi, et al.
Pageof 6